High rate of arterial complications in patients supported with extracorporeal life support for drug intoxication-induced refractory cardiogenic shock or cardiac arrest

被引:43
|
作者
Pozzi, Matteo [1 ]
Koffel, Catherine [2 ]
Djaref, Camelia [1 ]
Grinberg, Daniel [1 ]
Fellahi, Jean Luc [2 ]
Hugon-Vallet, Elisabeth [3 ]
Prieur, Cyril [3 ]
Robin, Jacques [1 ]
Obadia, Jean Francois [1 ]
机构
[1] Claude Bernard Univ, Louis Pradel Cardiol Hosp, Dept Cardiac Surg, 28 Ave Doyen Lepine, F-69500 Lyon, France
[2] Claude Bernard Univ, Louis Pradel Cardiol Hosp, Dept Anesthesia & ICU, Lyon, France
[3] Claude Bernard Univ, Louis Pradel Cardiol Hosp, Dept Cardiol, Lyon, France
关键词
Cardiotoxicity; cardiogenic shock; cardiac arrest; extracorporeal membrane oxygenation; lower limb ischemia; MEMBRANE-OXYGENATION; CARDIOPULMONARY BYPASS; VASCULAR COMPLICATIONS; PERFUSION; RESUSCITATION; ASSOCIATION; CANNULATION; ASSISTANCE; SURVIVAL; OUTCOMES;
D O I
10.21037/jtd.2017.06.81
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Cardiac failure is still a leading cause of death in drug intoxication. Extracorporeal life support (ECLS) could be used as a rescue therapeutic option in patients developing refractory cardiogenic shock or cardiac arrest. The aim of this report is to present our results of ECLS in the setting of poisoning from cardiotoxic drugs. Methods: We included in this analysis consecutive patients who received an ECLS for refractory cardiogenic shock or in-hospital cardiac arrest due to drug intoxication. The primary endpoint of our study was survival to hospital discharge with good neurological recovery after ECLS support. Results: Between January 2010 and December 2015, we performed 12 ECLS. Mean age was 44.2 +/- 17.8 years and there was a predominance of females (66.7%). Drug intoxication was mainly due to beta-blockers and/or calcium channel inhibitors (83.3%) and 5 (41.7%) patients had multiple drugs overdose. Weaning rate and survival to hospital discharge with good neurological recovery were 75% (9 patients). Among patients weaned from ECLS, mean duration of support was 2.4 +/- 1.1 days. Three (25%) patients underwent ECLS implantation during cardiopulmonary resuscitation, 2 (66.6%) of them died while on mechanical circulatory support (MCS). Six (50%) patients developed lower limb ischemia. Each patient was managed with ECLS decannulation: 2 (16.7%) patients underwent a concomitant iliofemoral thrombectomy, 3 (25%) needed further fasciotomy and the remaining patient (8.3%) required an amputation. Conclusions: Refractory cardiogenic shock due to drug intoxication is still one of the best indications for ECLS owing to the satisfactory survival with good neurological outcome in such a critically ill population. Further data are however necessary in order to best understand the possible relation between drug intoxication and lower limb ischemia, which was quite superior to the reported rates.
引用
收藏
页码:1988 / 1996
页数:9
相关论文
共 50 条
  • [1] Complications of veno-arterial extracorporeal membrane oxygenation for refractory cardiogenic shock or cardiac arrest
    Lee, Soo Youn
    Jeon, Ki-Hyun
    Lee, Hyun Jong
    Kim, Ji-Bak
    Fang, Ho-Jun
    Kim, Je Sang
    Kim, Tae Hoon
    Park, Jin-Sik
    Choi, Rak Kyeong
    Choi, Young Jin
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2020, 43 (01): : 37 - 44
  • [2] Metabolic Recovery During Refractory Cardiac Arrest and Cardiogenic Shock Using Extracorporeal Life Support
    Babar, Zud
    Ganushchak, Y. M.
    Vranken, N. P. A.
    Hendrix, R. H. J.
    Delnoij, T. S. R.
    Lorusso, R.
    Weerwind, P. W.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 5 - 5
  • [3] Extracorporeal life support for severe cardiogenic shock induced by diltiazem intoxication
    Srdanovic, Ilija
    Kovacevic, Mila
    Stefanovic, Maja
    Petrovic, Milovan
    Cankovic, Milenko
    Velicki, Lazar
    VOJNOSANITETSKI PREGLED, 2019, 76 (09) : 955 - 959
  • [4] The impact of complication of extracorporeal life support for acute myocardial infarction with refractory cardiogenic shock or cardiac arrest
    Lee, S. Y.
    Jeon, K. H.
    Kim, M. J.
    Kim, J. B.
    Jang, H. J.
    Kim, J. S.
    Lee, H. J.
    Kim, T. H.
    Park, J. S.
    Choi, Y. J.
    Lee, M. M.
    Choi, R. K.
    EUROPEAN HEART JOURNAL, 2018, 39 : 963 - 963
  • [5] Efficacy of Veno-Arterial Extracorporeal Life Support in Adult Patients with Refractory Cardiogenic Shock
    Kurniawati, E. R.
    van Kuijk, S. M. J.
    Vranken, N. P. A.
    Maessen, J. G.
    Weerwind, P. W.
    CLINICAL MEDICINE INSIGHTS-CIRCULATORY RESPIRATORY AND PULMONARY MEDICINE, 2022, 16
  • [6] Extracorporeal Life Support for Cardiogenic Shock or Cardiac Arrest Due to Acute Coronary Syndrome
    Sakamoto, Shingo
    Taniguchi, Norimasa
    Nakajima, Shunsuke
    Takahashi, Akihiko
    ANNALS OF THORACIC SURGERY, 2012, 94 (01): : 1 - 7
  • [7] Extracorporeal life support in patients with refractory cardiogenic shock: keep them awake
    Mohite, Prashant N.
    Kaul, Sundeep
    Sabashnikov, Anton
    Rashid, Naufal
    Fatullayev, Javid
    Zych, Bartlomiej
    Popov, Aron-Frederik
    Maunz, Olaf
    Patil, Nikhil P.
    Garcia-Saez, Diana
    DeRobertis, Fabio
    Bahrami, Toufan
    Amrani, Mohamed
    Banner, Nicholas R.
    Simon, Andre R.
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2015, 20 (06) : 755 - 760
  • [8] Outcome of elderly patients undergoing extracorporeal life support in refractory cardiogenic shock
    De Waha, S.
    Fuernau, G.
    Graf, T.
    Eitel, I.
    Desch, S.
    Wiedau, A.
    Lurz, P.
    Schuler, G.
    Thiele, H.
    EUROPEAN HEART JOURNAL, 2016, 37 : 601 - 601
  • [9] OUTCOME OF ELDERLY PATIENTS UNDERGOING EXTRACORPOREAL LIFE SUPPORT IN REFRACTORY CARDIOGENIC SHOCK
    de Waha, Suzanne
    Desch, Steffen
    Graf, Tobias
    Fuernau, Georg
    Eitel, Ingo
    Poess, Janine
    Stiermaier, Thomas
    Jobs, Alexander
    Ledwoch, Jakob
    Lurz, Philipp
    Schuler, Gerhard
    Thiele, Holger
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 1186 - 1186
  • [10] Use of Veno-Arterial Extracorporeal Life Support (VA ECLS) in Awake Patients in Refractory Cardiogenic Shock
    Kobsa, S.
    Vaynrub, A.
    Zhang, A.
    Singh, S. K.
    Fried, J. A.
    Yuzefpolskaya, M.
    Colombo, P. C.
    Sayer, G.
    Uriel, N.
    Kaku, Y.
    Wang, A. S.
    Naka, Y.
    Takeda, K.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S384 - S384